ROLE OF SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN VOIDING DYSFUNCTION
- 1 December 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 332 (8626-8627) , 1451-1453
- https://doi.org/10.1016/s0140-6736(88)90932-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Subcutaneous apomorphine in Parkinson’s diseasePublished by Springer Nature ,1989
- SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONSThe Lancet, 1988
- Micturition Disturbance in Parkinson's DiseaseBritish Journal of Urology, 1985
- Urethral Sphincter Abnormalities in ParkinsonismBritish Journal of Urology, 1983
- Neurourologic Findings in Parkinson’s DiseaseJournal of Urology, 1983
- THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRACEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSON'S DISEASEThe Lancet, 1979
- Neurogenic bladder in parkinsonism: effect of thalamotomyJournal of Neurosurgery, 1971
- SYNCHRONOUS CINE/PRESSURE/FLOW/CYSTO-URETHROGRAPHY WITH SPECIAL REFERENCE TO STRESS AND URGE INCONTINENCEBritish Journal of Urology, 1970
- Extrapyramidal inhibition of the urinary bladderBrain Research, 1967
- THE MEASUREMENT AND SIGNIFICANCE OF THE URINARY FLOW RATE1British Journal of Urology, 1966